Black Diamond Therapeutics, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2021
August 12, 2021 at 08:22 am EDT
Black Diamond Therapeutics, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2021. For the quarter, the company reported loss from operations of $34,715,000 against $15,028,000 a year ago. Net loss was $34,351,000 or $0.95 per basic and diluted share against $14,571,000 or $0.41 per basic and diluted share a year ago.
For the six months, the company reported loss from operations of $65,428,000 against $27,907,000 a year ago. Net loss was $64,652,000 or $1.79 per basic and diluted share against $26,716,000 or $0.92 per basic and diluted share a year ago.